Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029.
Cancer. 2023 Jan 15;129(2):264-271. doi: 10.1002/cncr.34565. Epub 2022 Nov 24.
Cancer. 2023.
PMID: 36420773
Free article.
Clinical Trial.
Association of Immune-Related Adverse Events and Efficacy Outcomes With Consolidation Pembrolizumab After Chemoradiation in Patients With Inoperable Stage III Non-Small-Cell Lung Cancer.
Shukla NA, Althouse S, Meyer Z, Hanna N, Durm G.
Shukla NA, et al.
Clin Lung Cancer. 2021 Jul;22(4):274-281. doi: 10.1016/j.cllc.2020.12.014. Epub 2021 Jan 23.
Clin Lung Cancer. 2021.
PMID: 33610454
Item in Clipboard
The Story of Angiogenesis Inhibitors in Non-small-cell Lung Cancer: The Past, Present, and Future.
Shukla NA, Yan MN, Hanna N.
Shukla NA, et al.
Clin Lung Cancer. 2020 Jul;21(4):308-313. doi: 10.1016/j.cllc.2020.02.024. Epub 2020 Mar 12.
Clin Lung Cancer. 2020.
PMID: 32291211
Review.
Item in Clipboard
Practical challenges in patients with stage III NSCLC receiving checkpoint inhibitors after chemoradiation.
Shukla NA, Hanna NH.
Shukla NA, et al.
Lung Cancer Manag. 2020 Feb 6;9(1):LMT23. doi: 10.2217/lmt-2020-0001.
Lung Cancer Manag. 2020.
PMID: 32256709
Free PMC article.
No abstract available.
Item in Clipboard
Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection.
Shornick LP, Wells AG, Zhang Y, Patel AC, Huang G, Takami K, Sosa M, Shukla NA, Agapov E, Holtzman MJ.
Shornick LP, et al. Among authors: shukla na.
J Immunol. 2008 Mar 1;180(5):3319-28. doi: 10.4049/jimmunol.180.5.3319.
J Immunol. 2008.
PMID: 18292557
Item in Clipboard
Cite
Cite